The Pharmacy Times® Women's Health Resource Center is a comprehensive resource for clinical news and expert insights on issues related to health conditions that affect women, including gynecological health and maternal health.
August 15th 2025
IDSA updated cUTI guidelines for men and women emphasize antibiotic selection, transition to oral therapy, and optimal treatment duration.
Women Pharmacists Day: The Evolution of Women’s Role in US Pharmacy Practice
October 12th 2021Although October has long been celebrated as National Pharmacy Month, it is only in recent years that female pharmacists have been celebrated for their contributions to the profession and patient care.
Read More
Pharmacy Focus Podcast: Women in Pharmacy Wednesday- Episode 6
October 6th 2021The Pharmacy Times® Pharmacy Focus podcast provides the latest industry news and information, thought-leader insights, clinical updates, patient counseling tools, and innovative solutions for the everyday practice and business of pharmacy.
Listen
FDA Approves Tisotumab Vedotin-tftv for Previously Treated Recurrent, Metastatic Cervical Cancer
September 21st 2021Trial results showed a 24% confirmed objective response rate with a median duration of response of 8.3 months among patients with cervical cancer who received tisotumab vedotin-tftv.
Read More
Study: Children of Mothers With Diabetes During Pregnancy Have Increased Risk of Eye Problems
September 10th 2021The research team analyzed the associations between maternal diabetes before or during pregnancy and the risk of high refractive error (RE), which are conditions in which there is a failure of the eye to properly focus images on the retina.
Read More
Eating More Plant Foods May Lower Heart Disease Risk in Young Adults, Older Women
September 2nd 2021Compared to women who followed the Portfolio Diet less frequently, those with the closest alignment were 11% less likely to develop any type of cardiovascular disease, 14% less likely to develop coronary heart disease, and 17% less likely to develop heart failure.
Read More
FDA Approves Pembrolizumab, Lenvatinib Combination Therapy for Advanced Endometrial Carcinoma
July 22nd 2021The FDA has approved pembrolizumab in combination with lenvatinib for the treatment of advanced endometrial carcinoma that is not microsatellite instability-high or mismatch repair deficient
Read More
Study Supports Recommendations to Avoid Pregnancy for at Least 12 Months After Bariatric Surgery
May 14th 2021More than half of all female patients who undergo bariatric surgery are of reproductive age, and the resulting weight loss improves fertility, as well as reducing the risk of gestational diabetes and hypertensive disorders during pregnancy.
Read More